VERAXA Biotech GmbH

veraxa biotech specializes in adc development combining cutting-edge solutions for targeted antibody discovery and bioconjugation. through biochemical and technological innovation, we strive to transform the way antibodies and antibody-drug conjugates (adcs) are created to develop more effective and safe therapies for patients. with our transformative technologies, we can streamline and derisk early bioconjugate development. we have established a rich pipeline of proprietary adcs and are collaborating with a number of partners to provide access to our unique research & development capabilities going from target to antibody to adc.